TAMPA, Fla., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Standard Dental Labs Inc. (OTCQB: TUTH) (“SDL” or the “Company”) today announced the acquisition, effective October 2, 2026, of substantially all of the operating assets of Dr. Tooth, LLC, the dental laboratory business also known as Sheen Dental Laboratory and Hansen Incarnati.

佛罗里达州坦帕市，2026年10月2日（环球新闻社）——Standard Dental Labs Inc.（OTCQB: TUTH）（“SDL”或“公司”）今日宣布，已于2026年10月2日生效收购Dr. Tooth, LLC（亦称为Sheen Dental Laboratory和Hansen Incarnati的牙科实验室业务）的绝大部分运营资产。

The acquisition expands SDL’s customer base and advances its strategy of consolidating Florida dental laboratories around regional production facilities..

此次收购扩大了SDL的客户群，并推进了其围绕区域生产设施整合佛罗里达州牙科实验室的战略。

Based on current operating levels, management estimates that the acquired business adds just over $800,000 in annualized revenue. Combined with SDL’s previously announced annualized revenue estimate of approximately $822,000 for its existing operations, the acquisition brings the Company’s estimated annualized revenue base to more than $1.6 million, nearly double the prior estimate.

根据当前的运营水平，管理层估计，所收购的业务带来的年化收入略高于80万美元。加上SDL此前宣布的现有业务年化收入约82.2万美元的估算，此次收购使公司的估计年化收入基础达到160万美元以上，几乎是此前估算的两倍。

These figures reflect management’s estimates of operating activity extended over 12 months and are not a forecast of revenue to be reported for calendar 2026..

这些数字反映了管理层对12个月内运营活动的估算，并不是对2026日历年将报告收入的预测。

SDL plans to move production for the acquired business to its Sarasota facility, bringing work currently outsourced to China into the Company’s Florida operations. Management believes domestic production can strengthen quality control and communication with dentists, help recover former customer relationships and increase utilization of the Sarasota facility.

SDL计划将被收购业务的生产转移至其萨拉索塔工厂，将目前外包给中国的工作纳入公司佛罗里达州的运营体系。管理层认为，本土生产能够加强质量控制和与牙医的沟通，有助于恢复原有的客户关系，并提高萨拉索塔工厂的利用率。

By adding volume to its existing production infrastructure, SDL expects the acquisition to improve the facility’s profitability as integration progresses..

SDL 预计，随着整合的推进，通过在其现有生产基础设施中增加产能，此次收购将提升该设施的盈利能力。

Management, which will included the existing Dr. Tooth management team of Denis Thaxton and Gavin White, believes these changes create an opportunity to rebuild the acquired business to more than $1.1 million in annualized revenue. Achieving that objective will depend on retaining current accounts, recovering customers and successfully transitioning production..

管理层（包括现有的Dr. Tooth管理团队Denis Thaxton和Gavin White）认为，这些变革为重建被收购业务、使其年化收入超过110万美元创造了机会。实现这一目标将取决于保留现有客户、挽回流失客户以及顺利过渡生产。

“Our focus is to bring this work back to Florida and give dentists direct access to the people making their restorations,” said James D. Brooks, President and Chief Executive Officer of Standard Dental Labs Inc. “We are adding an established customer base to our Sarasota operation, where the additional production can improve the economics of the facility.

“我们的重点是将这项业务迁回佛罗里达州，让牙医能够直接对接制作其修复体的技术人员。”Standard Dental Labs Inc. 总裁兼首席执行官詹姆斯·D·布鲁克斯表示。“我们将为萨拉索塔的运营中心引入一个成熟的客户群，通过增加产量来改善该设施的经济效益。

We also see a clear opportunity to win back business by giving customers the domestic production and responsive service they want.”.

我们还看到了一个明确的机会，通过为客户提供他们想要的国内生产和快速响应服务来赢回业务。

The transaction was structured as an asset purchase with a combination of cash and SDL common stock, including performance conditions tied to retained customer revenue.

该交易被构建为一项资产收购，对价由现金和SDL普通股组成，其中包括与留存客户收入挂钩的业绩条件。

About Standard Dental Labs Inc

关于 Standard Dental Labs Inc

Standard Dental Labs Inc. is a Florida-focused dental laboratory company pursuing growth through acquisitions and investment in domestic production capabilities. SDL serves dental practices through its laboratory operations and is focused on digital workflows, quality and responsive service. Its common stock trades on the OTCQB under the symbol TUTH..

Standard Dental Labs Inc. 是一家专注于佛罗里达州的牙科实验室公司，正通过收购和投资国内生产能力来寻求增长。SDL 通过其实验室运营为牙科诊所提供服务，并专注于数字化工作流程、质量和响应迅速的服务。其普通股在 OTCQB 市场交易，股票代码为 TUTH。

Forward Looking Statements

前瞻性陈述

This press release contains forward-looking statements within the meaning of the federal securities laws, including statements regarding anticipated revenue growth, future acquisitions, integration efforts, scalability, financing initiatives, operational synergies, and long-term shareholder value. Forward-looking statements generally can be identified by words such as “expects,” “intends,” “plans,” “believes,” “anticipates,” “will,” “may,” “continue,” and similar expressions..

本新闻稿包含联邦证券法律定义下的前瞻性陈述，包括有关预期收入增长、未来收购、整合工作、可扩展性、融资计划、运营协同效应以及长期股东价值的陈述。前瞻性陈述通常可以通过“期望”、“打算”、“计划”、“相信”、“预期”、“将”、“可能”、“继续”等词语及类似表述来识别。

These statements are based on current expectations, estimates, and assumptions that are subject to significant risks and uncertainties, many of which are beyond the Company’s control. Actual results may differ materially from those expressed or implied by such forward-looking statements due to a variety of factors, including integration risks, customer retention, operational performance, financing availability, regulatory considerations, market conditions, and other risks disclosed in the Company’s filings with the Securities and Exchange Commission and disclosures published through OTC Markets..

这些陈述基于当前的预期、估计和假设，受重大风险和不确定性的影响，其中许多风险超出公司的控制范围。由于各种因素，实际结果可能与这些前瞻性陈述所明示或暗示的结果存在重大差异，这些因素包括整合风险、客户保留、运营表现、融资可得性、监管考量、市场状况，以及公司在向美国证券交易委员会提交的文件中和通过OTC Markets发布的披露中揭示的其他风险。

The Company’s Regulation A offering statement referenced herein does not constitute an offer to sell or the solicitation of an offer to buy securities except pursuant to the qualified offering circular. Any investment should be made only after careful review of the offering materials and risk factors contained therein..

本文所提及的本公司A条例发行声明，除依据经资格的发行通函外，不构成出售证券的要约或购买证券要约的招揽。任何投资均应在仔细审阅发行材料及其所载风险因素后方可进行。

Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date made. Standard Dental Labs Inc. undertakes no obligation to update or revise forward-looking statements except as required by law.

提醒读者不要过度依赖前瞻性陈述，这些陈述仅在作出之日有效。Standard Dental Labs Inc. 没有义务更新或修订前瞻性陈述，除非法律另有要求。

Investor and Media Contact

投资者与媒体联系人

Standard Dental Labs Inc.

标准牙科实验室有限公司

424 E Central Blvd, Suite 308, Orlando, FL 32801

佛罗里达州奥兰多市中央大道东424号308室，邮编32801

Phone: (407) 789-1923

电话：(407) 789-1923

Email: info@sdl.care

邮箱：info@sdl.care

Investors: https://sdl.care/investors

投资者：https://sdl.care/investors

SOURCE: Standard Dental Labs Inc.

来源：Standard Dental Labs Inc.